Rapid growth is being seen in the study of circulating tumour cells, both in research and in the clinic.
Online PR News – 03-March-2014 – London United Kindom – Circulating Tumour cells (CTCs) are cancer cells that are shed from tumours into the vasculature and are found in the bloodstream. CTCs therefore represent a mobile population of cancer cells and are showing increasing importance diagnostically.
New 'real world' diagnostics-related market findings on circulating tumour cells are published this month by Biopharm Reports. This study investigated current clinical and research diagnostic activities of physicians and researchers relating to circulating tumour cells, as well their plans for growing these activities over the next three years.
Its findings provide market information on current and evolving diagnostic developments relating to circulating tumour cells, and assist companies in these markets to respond to laboratory users’ current needs and future plans.
Biopharm Reports specialises in carrying out market studies of techniques and applications used in life science laboratories and clinics. All our studies involve the participation of scientists and clinicians and investigate in-depth, key areas of their current use of specialised laboratory techniques, and their plans for using these techniques over the next three years.